Chronic Kidney Disease: Decreasing Serum Klotho Levels Predict Adverse Renal and Vascular Outcomes

Overview

Journal Int J Nephrol

Publisher Wiley

Specialty Nephrology

Date 2024 Nov 15

PMID 39544340

Authors

Abhijit Konnur

Sishir Gang

Umapati Hegde

Hardik Patel

Akash Pandya

Nitiraj Shete

Affiliations

Soon will be listed here.

Abstract

Soluble alpha Klotho (s.Klotho) is an emerging marker for chronic kidney disease (CKD) prognosis. The objective was to study the association between s.Klotho and CKD-related decrease in glomerular filtration rate (GFR), bone and vascular damage. A total of 118 patients with CKD stage 2-4 were enrolled and 107 patients continued in the study. Clinical and laboratory parameters were recorded at time of enrollment and 12 months. A double sandwich ELISA for s.Klotho was recorded in controls ( = 25) and patients' serum samples at 6 months ( = 107) and 12 months ( = 102). Primary endpoints like 40% or more fall in GFR, a requirement for renal replacement therapy (RRT), and death with different grades of s.Klotho deficiency were studied. Of the 107 patients (80 male and 27 female), mean s.Klotho was 3.46 ng/mL (02.3-04.2). The GFR fall was significantly different ( value < 0.0001) in the different grades of s.Klotho deficiency with Grade 4 s.Klotho deficiency (0.1-2.99 ng/mL) having the maximum fall of GFR at 9.2 mL/min/1.73 m (04.8-12.0) and minimum in Grade 2 (3-5.99 ng/mL) at 1.35 mL/min/1.73 m2 (03.0-02.75). The Ankle Brachial Pressure Index positively correlated with s.Klotho and the correlation coefficient was 0.536 (0.382-0.662) ( < 0.001). The carotid intimal medial thickness negatively correlated with s.Klotho and the correlation coefficient was -0.712 (95% CI: -0.797--0.601, < 0.001). All five deaths had s.Klotho Grade 4 (severe) deficiency. The event-free survival rate was maximum (100%) in Grade 2 Klotho deficiency and lowest (55%) in Grade 4 s.Klotho deficiency. s.Klotho levels decreased significantly in patients with progressive kidney failure. s.Klotho levels significantly correlated with the presence of vascular disease. Death and need for RRT were significantly more in patients with severe s.Klotho deficiency.

References

Kooman J, Broers N, Usvyat L, Thijssen S, van der Sande F, Cornelis T . Out of control: accelerated aging in uremia. Nephrol Dial Transplant. 2012; 28(1):48-54. DOI: 10.1093/ndt/gfs451. View

Kasliwal R, Bansal M, Desai N, Kotak B, Raza A, Vasnawala H . A Study to derive distribution of carotid intima media thickness and to determine its COrrelation with cardiovascular Risk factors in asymptomatic nationwidE Indian population (SCORE-India). Indian Heart J. 2016; 68(6):821-827. PMC: 5143805. DOI: 10.1016/j.ihj.2016.04.009. View

Kooman J, Kotanko P, Schols A, Shiels P, Stenvinkel P . Chronic kidney disease and premature ageing. Nat Rev Nephrol. 2014; 10(12):732-42. DOI: 10.1038/nrneph.2014.185. View

Donate-Correa J, Ferri C, Martin-Nunez E, Perez-Delgado N, Gonzalez-Luis A, Mora-Fernandez C . Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease. Sci Rep. 2021; 11(1):15877. PMC: 8342510. DOI: 10.1038/s41598-021-95488-4. View

Kumar K, Lakshmi A, Rao P, Das G, Kumar V . Carotid intima-media thickness in patients with end-stage renal disease. Indian J Nephrol. 2010; 19(1):13-4. PMC: 2845187. DOI: 10.4103/0971-4065.50674. View

Aboyans V, Criqui M, Abraham P, Allison M, Creager M, Diehm C . Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012; 126(24):2890-909. DOI: 10.1161/CIR.0b013e318276fbcb. View

Hu M, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B . Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J. 2010; 24(9):3438-50. PMC: 2923354. DOI: 10.1096/fj.10-154765. View

Giachelli C . The emerging role of phosphate in vascular calcification. Kidney Int. 2009; 75(9):890-7. PMC: 2807740. DOI: 10.1038/ki.2008.644. View

Lindberg K, Amin R, Moe O, Hu M, Erben R, Wernerson A . The kidney is the principal organ mediating klotho effects. J Am Soc Nephrol. 2014; 25(10):2169-75. PMC: 4178446. DOI: 10.1681/ASN.2013111209. View

10.

Manou E, Thodis E, Arsos G, Pasadakis P, Panagoutsos S, Papadopoulou D . Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients. Kidney Blood Press Res. 2020; 45(6):900-915. DOI: 10.1159/000510351. View

11.

Rotondi S, Pasquali M, Tartaglione L, Muci M, Mandanici G, Leonangeli C . Soluble α -Klotho Serum Levels in Chronic Kidney Disease. Int J Endocrinol. 2015; 2015:872193. PMC: 4383388. DOI: 10.1155/2015/872193. View

12.

Seiler S, Rogacev K, Roth H, Shafein P, Emrich I, Neuhaus S . Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4. Clin J Am Soc Nephrol. 2014; 9(6):1049-58. PMC: 4046724. DOI: 10.2215/CJN.07870713. View

13.

Zou D, Wu W, He Y, Ma S, Gao J . The role of klotho in chronic kidney disease. BMC Nephrol. 2018; 19(1):285. PMC: 6198535. DOI: 10.1186/s12882-018-1094-z. View

14.

Hu M, Shi M, Zhang J, Quinones H, Griffith C, Kuro-O M . Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol. 2010; 22(1):124-36. PMC: 3014041. DOI: 10.1681/ASN.2009121311. View

15.

Zoccali C, Vanholder R, Massy Z, Ortiz A, Sarafidis P, Dekker F . The systemic nature of CKD. Nat Rev Nephrol. 2017; 13(6):344-358. DOI: 10.1038/nrneph.2017.52. View

16.

Drew D, Katz R, Kritchevsky S, Ix J, Shlipak M, Gutierrez O . Association between Soluble Klotho and Change in Kidney Function: The Health Aging and Body Composition Study. J Am Soc Nephrol. 2017; 28(6):1859-1866. PMC: 5461794. DOI: 10.1681/ASN.2016080828. View

17.

Kim H, Nam B, Kim D, Kang M, Han J, Lee M . Circulating α-klotho levels in CKD and relationship to progression. Am J Kidney Dis. 2013; 61(6):899-909. DOI: 10.1053/j.ajkd.2013.01.024. View

18.

Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T . Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390(6655):45-51. DOI: 10.1038/36285. View

19.

Pavik I, Jaeger P, Ebner L, Wagner C, Petzold K, Spichtig D . Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant. 2012; 28(2):352-9. DOI: 10.1093/ndt/gfs460. View